Cell & Gene Therapy Fueled Large Surge in Clinical Holds Last Year

FDA clinical holds saw a sharp increase in 2021, propelled in large part by holds on cell and gene therapy trials, according to an analysis by investment banking firm Jefferies that evaluated holds over the past 12 years.
Source: Drug Industry Daily